Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Other Non Operating Income (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Other Non Operating Income for 6 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 205.9% year-over-year to $8.3 million, compared with a TTM value of -$16.4 million through Dec 2025, down 51.83%, and an annual FY2025 reading of -$10.7 million, up 20.95% over the prior year.
  • Other Non Operating Income was $8.3 million for Q4 2025 at Roivant Sciences, up from -$5.7 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $11.1 million in Q4 2022 and bottomed at -$11.2 million in Q2 2025.
  • Average Other Non Operating Income over 5 years is -$1.4 million, with a median of -$1.5 million recorded in 2023.
  • Peak annual rise in Other Non Operating Income hit 537.33% in 2022, while the deepest fall reached 909.7% in 2022.
  • Year by year, Other Non Operating Income stood at -$2.5 million in 2021, then skyrocketed by 537.33% to $11.1 million in 2022, then tumbled by 80.9% to $2.1 million in 2023, then crashed by 472.96% to -$7.9 million in 2024, then skyrocketed by 205.9% to $8.3 million in 2025.
  • Business Quant data shows Other Non Operating Income for ROIV at $8.3 million in Q4 2025, -$5.7 million in Q3 2025, and -$11.2 million in Q2 2025.